Technical Articles

TR-FRET KRAS [G12D]/CRBN PROTAC 试剂盒相关研究进展
Research progress on TR-FRET KRAS/[G12D] CRBN PROTAC assay kit-related studies
发布时间 2026-04-14
RAS is the most widely mutated oncogene in tumors, occurring in nearly 30% of human cancers. The RAS family includes three subtypes: KRAS, HRAS, and NRAS, with KRAS gene mutations accounting for approximately 85% of RAS family mutations.
View details
  • Cancer
  • KRAS [G12D]/CRBN
  • Mutated Oncogene
  • Pancreatic Cancer
Total 1
  • 1
Go to